a BavaRiAn eValuatiOn of Dorsal Root Ganglion (DRG) Stimulation for the Treatment for Chronic Post Surgical Pain of the Groin

Study Overview
=================
Brief Summary
-----------------
15-SMI-2013 is a post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of chronic post surgical groin pain

Official Title
-----------------
BRAVO: a BavaRiAn eValuatiOn of DRG Stimulation for the Treatment for Chronic Post Surgical Pain of the Groin

Conditions
-----------------
Post Surgical Groin Pain

Intervention / Treatment
-----------------
* Device: Implantation with the commercially available Axium neurostimulator


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: The patient is at least 18 years old The patient is willing and able to comply with the examination schedule and the trial schedule. The patient has suffered from chronic post-surgical neuropathic groin pain for at least 6 months Conservative treatments of the chronic pain including medication, physiotherapy and interventions have been exhausted The pain level at the time of the baseline examination is at least 60mm on the visual analogue scale (VAS) in the primary pain area (groin pain) The patient is able to give consent in writing Exclusion Criteria: Pregnant or breastfeeding patients or those who plan to become pregnant during the study It has been established in an examination by the tester that the pain has significantly worsened or changed its characteristics in the course of the previous month. In the last 30 days, the patient has been treated with corticosteroids on an area scheduled for the stimulation. In the last 3 months, the patient has been treated with radio frequency therapy on an area scheduled for the stimulation. The patient has already been treated with an active implantable device, including an implantable cardioverter defibrillator, pacemaker, spinal cord stimulator or an intrathecal medication pump. The patient is not able to operate the stimulation device The patient is currently suffering from an infection The patient has participated in another clinical study in the last 30 days The patient has a coagulation disorder or is taking anti-coagulants, which would make participation impossible, as per the study doctor The patient has been diagnosed with a malignancy in the past 2 years

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Treated subjects<br>All subjects recruited and treated with the Axium neurostimulator | Device: Implantation with the commercially available Axium neurostimulator<br> <br> |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Pain Relief - Assessed by Change in Pain Intensity Assessed using a Visual Analogue Scale (VAS) from Pre-Treatment Baseline |  | Post treatment at; 1 week and 1, 3, 6 and12 months |